# FDA Inspection 973494 - Sever Pharma Solutions - June 01, 2016

Source: https://www.keypedia.com/records/fda_inspections/sever-pharma-solutions/aea4a193-17e7-45cc-ba73-bec6b9e01307
Source feed: FDA_Inspections

> FDA Inspection 973494 for Sever Pharma Solutions on June 01, 2016. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 973494
- Company Name: Sever Pharma Solutions
- Inspection Date: 2016-06-01
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1268673 - 2023-05-12](https://www.keypedia.com/records/fda_inspections/sever-pharma-solutions/f9c147ab-188f-44c4-b690-6f3a025d08d7)
- [FDA Inspection 1204531 - 2023-03-31](https://www.keypedia.com/records/fda_inspections/sever-pharma-solutions/0a490437-fb38-498f-a40e-7157763a22e9)
- [FDA Inspection 1093984 - 2017-11-23](https://www.keypedia.com/records/fda_inspections/sever-pharma-solutions/a788da8a-a172-498d-bb5b-120a96b08ee0)
- [FDA Inspection 871578 - 2014-03-27](https://www.keypedia.com/records/fda_inspections/sever-pharma-solutions/7513e5ee-4b15-4d1f-a2ba-fbf50481f058)

Company: https://www.keypedia.com/companies/sever-pharma-solutions/d4aaa41d-8c80-4520-bc82-45ae10cb4795

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c